Insights into Molecular cancer therapy: NOS-2 suppresses the expression of tumor suppressor Sprouty-2 via up regulation of its target gene, 24/February/2014, 9.36 am

Insights into the regulation of cell cycle checkpoints: Oct4/Sox2 regulates kinetochore biorientation via up regulation of its target gene, 25/February/2014, 9.29 am
February 25, 2014
Tumorigenesis: The oncomir miRNA-24-1 decreases the processing of let-7a via down regulation of its target gene, 26/February/2014, 7.44 am
February 26, 2014
Show all

Noble Laureate in Medicine (1998) Prof. Dr Feirid  (The University of Texas, Houston, Texas, USA) has suggested in a number of papers that inhibition of NOS2 (Nitric oxide synthase) may have a therapeutic value in a number of cancers.

In connection with this finding, Dr L Boominathan, Director-cum-chief scientist of GBMD, reports that: Molecular insights into Cancer therapy: NOS-2 suppresses the expression of  tumor suppressor Sprouty-2 via up regulation of its target gene. This study provides mechanistic insights into how inhibition of NOS-2 may improve caner therapy.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Insights into Molecular cancer therapy: NOS-2 suppresses the expression of  tumor suppressor Sprouty-2 via up regulation of its target gene, 24/February/2014, 9.36 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.